(Q54384984)

29 May 2018

title

Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer. (English)

1 reference

29 May 2018

author name string

Yuichi Hisamatsu

1

1 reference

29 May 2018

Eriko Tokunaga

2

1 reference

29 May 2018

Nami Yamashita

3

1 reference

29 May 2018

Sayuri Akiyoshi

4

1 reference

29 May 2018

Satoko Okada

5

1 reference

29 May 2018

Yuichiro Nakashima

6

1 reference

29 May 2018

Kenji Taketani

7

1 reference

29 May 2018

Shinichi Aishima

8

1 reference

29 May 2018

Yoshinao Oda

9

1 reference

29 May 2018

Masaru Morita

10

1 reference

29 May 2018

Yoshihiko Maehara

11

1 reference

29 May 2018

publication date

11 January 2014

1 reference

29 May 2018

published in

Breast Cancer

1 reference

29 May 2018

volume

22

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

520-528

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s12282-013-0515-x

exact match

0 references

cites work

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Gene-expression-based prognostic assays for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

GATA-3: an unexpected regulator of cell lineage determination in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Transcription factor GATA-3 is required for development of the T-cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Forkhead transcription factors: key players in development and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Estrogen receptor target gene: an evolving concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

FOXA1 is a key determinant of estrogen receptor function and endocrine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

FOXA1 is an independent prognostic marker for ER-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

GATA-3 expression as a predictor of hormone response in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-013-0515-X

10.1007/S12282-013-0515-X

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018